Gene plays vital role in controlling appetite for salt and risk of blood pressure

NewsGuard 100/100 Score

Scientists have shed light on why some people crave salty food, even when they know it can seriously damage their health.

The study helps researchers understand how the brain controls our appetite for salt, and how it impacts on blood pressure levels.

The findings suggest it could soon be possible to offer heart disease patients a medicine that helps them manage their salt intake and curb the adverse effects of high blood pressure.

Scientists modified mice to remove a gene in a small number of cells in the mouse brain. This gene is known to be linked with high blood pressure in humans but the way this is controlled is unclear.

Removing the gene caused the mice to develop a strong appetite for salt - when offered a choice of normal drinking water or saltwater, they consumed three times more saltwater than unmodified mice.

The trial also showed that the modified mice went on to experience high blood pressure for as long as they drank saltwater. When the saltwater was removed their blood pressure returned to normal.

The findings suggest that the gene plays an important role in controlling both the appetite for salt, and its effect in raising blood pressure, scientists say.

The team will now research whether an affordable drug - already used to treat heart disease in some countries - can help to bring salt intake under control in patients with heart failure.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Lurie Children's Hospital administers first gene therapy for Duchenne muscular dystrophy in Illinois